(!.#0&3\1#."\."\\ &)1\0&)#.3\P9AAL:8:L<8=Z<8?QK\,)'\."#-\*,-*.#0L\."\/,,(.\
-./3\,-/&.-\,\#(\&#(\1#."\*,0#)/-\-./#-\(L\&.")/!"\().\#(*((.\*,#.),-L\
."3\'#!".\) ,\(\2*&(.#)(\ ),\."\#(#,.\#'*.\)(\\ &)1\#(\()(Z\*.#(.-\(\
."\#(,-\,#-%\ ),\&).\ ),'.#)(K\
6.4 STUDY LIMITATIONS
"\ -.,)%\ *)*/&.#)(\ #(&/\ \ ,&.#0&3\ -'&&\ (/',\ ) \ *.#(.-L\ 1"#"\ '3\ \ )(-#,\ -\ #.-\ '#(\ &#'#..#)(K\ "\ \ ,#.,#\ 1,\ ().\ 0#&&\ .\ ."\ .#'\ ) \ ,,/#.#(!\ (\ ."/-\ ."\ *)*/&.#)(\ -&.#)(\ )(.#(\ !,.,\ ".,)!(#.3K\ ),)0,L\
)'*&.\2&/-#)(\) \\1-\().\*)--#&L\/-\\#-\().\#(0,#&3\,)!(#4\1#."\
:<"\\')(#.),#(!\P<8@QK\"\-./3\ )&&)1Z/*\&-.\)(&3\;\')(."-\(\.", ),L\&.Z )(-.\-\),\-.,)%-\1,\().\#(.# #K\\
"\).",\.1)\-./#-\)'*,#-\\&,!\)"),.L\/.\)(&3\)(\)-,0,\0&/.\."\
\'),*")&)!#-\(\\,.#)-\#(\."\'$),#.3\) \-(-K\)10,L\.",\1-\\-)(\
)-,0,\1")\'-/,\."\\0&/-\) \A?\)(-/.#0\*.#(.-\(\#.\1-\ )/(\.".\."\
#(.,Z)-,0,\ ,*,)/##&#.3\ **,\ .)\ \ !))\ ,!,#(!\ \ '),*")&)!#-\ (\
2&&(.\1#."\,-*.\.)\\,.#)-K\\
"\\-./3\*)*/&.#)(\)(.#(\'),\1)'(\(\."\-/!,)/*\) \\*.#(.-\
1-\ ,.",\ -'&&K\ ( ),./(.&3L\ ."\ )(.,)&\ *.#(.-\ -/ ,\ ,)'\ 0,#)/-\ %!,)/(\
#---\(\.", ),\."3\'3\().\\ /&&3\)(-#,\-\\"&."3\*)*/&.#)(K\&.")/!"\
"&."3\-/$.-\1)/&\"0\(\."\)*.#'&\*)*/&.#)(L\."\&%\) \\&#(#&\#(#.#)(\
.".\ 1)/&\ ,+/#,\ #'!#(!\ 1)/&\ "0\ '\ \ -(-\ /(."#&K\ "\ -./3\ &%\
#( ),'.#)(\)(\\0)&/'L\."#%(--\(\),# #\-#4L\\0)&/'\(\$.#)(\ ,.#)(L\
(\ \ ",.,#-.#-K\ (\ #.#)(L\ ",.\ ,.-\ (\ &))\ *,--/,-\ 1,\ ().\ )&&.\
/,#(!\."\-(-K\"\1#!".\-../-\1-\----\,.,)-*.#0&3L\#KK\."\ \0&/-\1,\
().\(--,#&3\,!#-.,\.\."\2.\.#'\) \K\ (\."\\#'!-L\."\*,-(\) \
&# #\ ),)(,3\ ,.,#-\ )'*&#.\ ."\ ----'(.\ ) \ -.()-#-K\ .#(.-\ 1,\ #'!\
/,#(!\'#Z#-.)&L\1"#"\#-\\()(Z)*.#'&\*"-\# \)(\1#-"-\.)\0&/.\."\'2#'&\
\ &(!."-\ ),\ )'*,\ \ 0&/-\ 1#."\ K\ #."\ ,!,\ .)\ ."\ ),#!#(&\ #'!#(!\
#(#.#)(L\ (Z-3-.)&#\ #'!-\ 1)/&\ ().\ "0\ "\ (3\ #!()-.#\ 0&/\ (\ .", ),\
1)/&\().\"0\(\$/-.# #&K\ (\#.#)(L\-\,\.3*#&&3\'-/,\3\."\\
)-.#/'\,\,.",\."(\."\.#*\) \."\L\1"#"\)'*&#.\."\)'*,#-)(\1#."\).",\
-./#-\P<8AQK\
\
4
4
"\ )&&)1#(!\)(&/-#)(-\(\\,1(\ ,)'\."\#(#0#/&\-./#-\P Z Q\#(\."#-\."-#-M\\
9K \'),*")&)!#&\&--# #.#)(\# ,\.1(\."\-.,)%\*)*/&.#)(\(\
"&."3\)(.,)&-K\(Z&)\(\"#!"Z0)&/'#()/-\-\1,\)0,,*,-(.\
')(!\."-\-.,)%Y \*.#(.-K\"\/-\) \."\\'),*")&)!#&\&--# #.#)(\
0#-\3\(!\.\&K\-'-\#()(-#-.(.N\."#-\#-\, &.\#(\."\2.(-#0\
0,##&#.3\#(\#(.,Z)-,0,\,*,)/##&#.3\')(!\-./#-N\."/-\#.\&%-\&#(#&\
-##&#.3\#(\#.-\/,,(.\ ),'K\P Q\
:K \ (\."#-\&,!\()(Z-.,)%\*)*/&.#)(L\)3\-#4\#(2\\&(!."\),,&.\
*)-#.#0&3\1#."\!#(!K\/,.",'),L\ '&-\*)----\#(,-\,&.#0\\
&(!."-\(\'&-\2"##.\(\2--\) \'/&.#Z&)\-K\#(!\)0,1#!".\
--)#.\1#."\\'),*")&)!#&\&---\1#."\'),\&)-K\P Q\
;K \#."\,-*.\.)\..(/.#)(\,.#)\) \."\)(.,-.\!(.L\*.#(.-\1#."\-"),.\(\)(Z
&)\\'),*")&)!3\#-*&3\&)1,\0&/-L\1"#"\, &.-\."\,-\&))\
&)1\#(\."\K\P Q\
\\
\ \
4
4
#(\,).#\,.,3\\#-\,)/.#(&3\*, ),'\#(\-.,)%\*.#(.-L\)'#(#(!\,#\\#-\
-.,#!". ),1,\(\/- /&\ ),\----#(!\*).(.#&\\.",)'/-\(\\'),*")&)!3K\
),)0,L\ \ '),*")&)!3\ (\ #.-\ #&&#(!\ *,)*,.#-\ '3\ \ 0&/.\ #(\ *.#(.-\
/(,!)#(!\\1#."\\&)1\),\'),.\*,.-.\*,)#&#.3\ ),\K\"-\\,&.\
.),-\,\.",3\-#'/&.()/-&3\--#&\(\*,)0#\/- /&\, ,(\.\,!,#(!\
()(Z-.,)%\*.#(.-K\
\-#!(# #(.\,-\#(\."\Y\\,.#)L\#(#,.&3\, &.#(!\*)),,\&))\ &)1\#(\
K\)(."&--L\#.\#-\().\&,\# \(3\\'),*")&)!#&\ ./,\#.-& \(\\.!),#4\
-\ "4,)/-\ (\ 1)/&\ \ &\ .)\ /-\ \ .",)'/-\ 1#.")/.\ ."\ /,(\ ) \ -)'\
*.")&)!#&\ )(#.#)(K\ ),\ 2'*&L\ -)'\ -/,!#&\ ,')0&-\ ) \ \ ,\ *, ),'\
-#'/&.()/-&3\1#."\,#\*,)/,-\(\#.\1)/&\\#'*),.(.\.)\%()1\# \,')0&\) \\
,.#(\.3*\) \\1)/&\\( ##&\),\().K\0&/.#(!\."\#((.\(./,\) \\,&.\
.)\ ."\ ,#-%\ ),\ .",)'/-\ 1)/&\ ,+/#,\ &,!\ -3-.'.#\ )&&)1Z/*\ -./#-\ #(\ &)1Z,#-%\
*.#(.-\1")\-/ ,\ ,)'\-/-*.\,#)')&#\-.,)%N\")10,L\."\)/.)'\1)/&\\
) \&#(#&\0&/K\\
\ \
4
4
(1) Welch W. A System of Medicine. 2nd ed. London: Macmillan and Co Limited; 1909.
(2) Virchow R. Neuer Fall von tödlicher Embolie der Lungenarterie. Arch Pathol Anat 1856(10):225-228.
(3) Aschoff L. Thrombosis. Arch Intern Med 1913(12):503-525.
(4) Welch WH. Thrombosis and Embolism. System of Medicine New York: Macmillan & Co; 1898. p. 155-285.
(5) Madden JL. Resection of the left auricular appendix; a prophylaxis for recurrent arterial emboli. J Am Med Assoc 1949;140(9):769-772.
(6) Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996;61(2):755-759.
(7) Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation 2017;135(10):e603.
(8) Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. The Lancet 2008;371(9624):1612-1623.
(9) Chambers BR, Norris JW, Shurvell BL, Hachinski VC. Prognosis of acute stroke. Neurology 1987;37(2):221-225.
(10) Joo H, George MG, Fang J, Wang G. A literature review of indirect costs associated with stroke. J Stroke Cerebrovasc Dis 2014;23(7):1753-1763.
(11) Fischer U, Arnold M, Nedeltchev K, Schoenenberger RA, Kappeler L, Höllinger P, et al. Impact of comorbidity on ischemic stroke outcome. Acta Neurol Scand 2006;113(2):108-113.
(12) Johnson WD, Ganjoo AK, Stone CD, Srivyas RC, Howard M. The left atrial appendage: our most lethal human attachment! Surgical implications. Eur J Cardiothorac Surg 2000;17(6):718-722.
(13) Al-Saady NM, Obel OA, Camm AJ. Left atrial appendage: structure, function, and role in thromboembolism. Heart 1999;82(5):547-554.
(14) Saygi S. Atrial Fibrillation and the Role of LAA in Pathophysiology and Clinical Outcomes? J Atr Fibrillation 2012;5(3):480.
(15) Beigel R, Wunderlich NC, Ho SY, Arsanjani R, Siegel RJ. The left atrial appendage: anatomy, function, and noninvasive evaluation. JACC Cardiovasc Imaging 2014;7(12):1251-1265.
(16) Yu C, Khattab AA, Bertog SC, Lee APW, Kwong JSW, Sievert H, et al. Mechanical antithrombotic intervention by LAA occlusion in atrial fibrillation. Nat Rev Cardiol 2013;10(12):707-722.
(17) Budge LP, Shaffer KM, Moorman JR, Lake DE, Ferguson JD, Mangrum JM. Analysis of in vivo left atrial appendage morphology in patients with atrial fibrillation: a direct comparison of transesophageal echocardiography, planar cardiac CT, and segmented three-dimensional cardiac CT. J Interv Card Electrophysiol 2008;23(2):87-93.
(18) Walker DT, Humphries JA, Phillips KP. Anatomical analysis of the left atrial appendage using segmented, three-dimensional cardiac CT: a comparison of patients with paroxysmal and persistent forms of atrial fibrillation. J Interv Card Electrophysiol 2012;34(2):173-179.
(19) Veinot JP, Harrity PJ, Gentile F, Khandheria BK, Bailey KR, Eickholt JT, et al. Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy hearts: implications for echocardiographic examination. Circulation 1997;96(9):3112-3115.
(20) Goldman ME, Pearce LA, Hart RG, Zabalgoitia M, Asinger RW, Safford R, et al. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). J Am Soc Echocardiogr 1999;12(12):1080-1087.
(21) Lupercio F, Carlos Ruiz J, Briceno DF, Romero J, Villablanca PA, Berardi C, et al. Left atrial appendage morphology assessment for risk stratification of embolic stroke in patients with atrial fibrillation: A meta-analysis. Heart Rhythm 2016;13(7):1402-1409.
(22) Ernst G, Stöllberger C, Abzieher F, Veit-Dirscherl W, Bonner E, Bibus B, et al. Morphology of the left atrial appendage. Anat Rec 1995;242(4):553-561.
(23) Stöllberger C, Ernst G, Bonner E, Finsterer J, Slany J. Left atrial appendage morphology: comparison of transesophageal images and postmortem casts. Z Kardiol 2003;92(4):303-308.
(24) Romero J, Cao JJ, Garcia MJ, Taub CC. Cardiac imaging for assessment of left atrial appendage stasis and thrombosis. Nat Rev Cardiol 2014;11(8):470-480.
(25) Hatano S. Variability of the diagnosis of stroke by clinical judgement and by a scoring method. Bulletin of the World Health Organization 1976;54(5):533.
(26) Terveyden- ja hyvinvoinnnin laitos. Aivohalvausten tapausmäärät. Available at:
https://www.thl.fi/fi/web/kansantaudit/sydan-ja-verisuonitaudit/sydan-ja-verisuonitautirekisteri/aivohalvaukset/raakaluvut. Accessed Aug 11, 2017.
(27) Aivoinfarkti ja TIA - Käypä hoito. 2016; Available at:
http://www.kaypahoito.fi/web/kh/suositukset/suositus?id=hoi50051. Accessed Aug 11, 2017.
(28) Terveyden ja hyvinvoinnin laitos. PERFormance, Effectiveness and Cost of Treatment episodes (PERFECT). Available at: http://www.thl.fi/fi/tutkimus-ja-asiantuntijatyo/hankkeet-ja-ohjelmat/perfect.
Accessed Aug 11, 2017.
(29) Feigin VL, Roth GA, Naghavi M, Parmar P, Krishnamurthi R, Chugh S, et al. Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet Neurology 2016;15(9):913-924.
(30) Putaala J, Metso AJ, Metso TM, Konkola N, Kraemer Y, Haapaniemi E, et al. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke 2009;40(4):1195-1203.
(31) Brett M. Kissela, Jane Khoury, Dawn Kleindorfer, Daniel Woo, Alexander Schneider, Kathleen Alwell, et al. Epidemiology of Ischemic Stroke in Patients With Diabetes. Diabetes Care 2005;28(2):355.
(32) Cordonnier C, Sprigg N, Sandset EC, Pavlovic A, Sunnerhagen KS, Caso V, et al. Stroke in women - from evidence to inequalities. Nat Rev Neurol 2017.
(33) Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24(1):35-41.
(34) Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O'Donnell MJ, et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol 2014;13(4):429-438.
(35) Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S, et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke 2001;32(11):2559-2566.
(36) Nouh A, Remke J, Ruland S. Ischemic posterior circulation stroke: a review of anatomy, clinical presentations, diagnosis, and current management. Frontiers in neurology 2014;5:30.
(37) Kim JS, Caplan LR. Clinical Stroke Syndromes. Front Neurol Neurosci 2016;40:72-92.
(38) Balami JS, Chen RL, Buchan AM. Stroke syndromes and clinical management. QJM 2013;106(7):607-615.
(39) Ferro JM. Cardioembolic stroke: an update. Lancet Neurol 2003;2(3):177-188.
(40) Nixon JV, Aurigemma GP, Bolger AF. AHA Clinical Cardiac Consult. 3rd ed. Philadelphia: Wolters Kluwer Health; 2010.
(41) Caplan LR, Wityk RJ, Glass TA, Tapia J, Pazdera L, Chang H, et al. New England Medical Center Posterior Circulation registry. Ann Neurol 2004;56(3):389-398.
(42) Adria Arboix, Josefina Alioc. Cardioembolic Stroke: Clinical Features, Specific Cardiac Disorders and Prognosis. Current Cardiology Reviews 2010;6(3):150-161.
(43) Ay H, Furie KL, Singhal A, Smith WS, Sorensen AG, Koroshetz WJ. An evidence-based causative classification system for acute ischemic stroke. Ann Neurol 2005;58(5):688-697.
(44) Boiten J, Lodder J. Lacunar infarcts. Pathogenesis and validity of the clinical syndromes. Stroke 1991;22(11):1374-1378.
(45) Yesilot Barlas N, Putaala J, Waje-Andreassen U, Vassilopoulou S, Nardi K, Odier C, et al. Etiology of first-ever ischaemic stroke in European young adults: the 15 cities young stroke study. Eur J Neurol 2013;20(11):1431-1439.
(46) Nouh A, Hussain M, Mehta T, Yaghi S. Embolic Strokes of Unknown Source and Cryptogenic Stroke:
Implications in Clinical Practice. Frontiers in neurology 2016;7:37.
(47) Jickling GC, Stamova B, Ander BP, Zhan X, Liu D, Sison S, et al. Prediction of cardioembolic, arterial, and lacunar causes of cryptogenic stroke by gene expression and infarct location. Stroke 2012;43(8):2036-2041.
(48) Weimar C. Stroke of undetermined cause: workup and secondary prevention. Curr Opin Neurol 2016;29(1):4-8.
(49) Putaala J, Nieminen T, Haapaniemi E, Meretoja A, Rantanen K, Heikkinen N, et al. Undetermined stroke with an embolic pattern--a common phenotype with high early recurrence risk. Ann Med 2015;47(5):406-413.
(50) Hart RG, Catanese L, Perera KS, Ntaios G, Connolly SJ. Embolic Stroke of Undetermined Source: A Systematic Review and Clinical Update. Stroke 2017;48(4):867-872.
(51) Kamel H, Healey JS. Cardioembolic Stroke. Circ Res 2017;120(3):514-526.
(52) Brotman DJ, Deitcher SR, Lip GYH, Matzdorff AC. Virchow's triad revisited. South Med J 2004;97(2):213-214.
(53) del Zoppo GJ. Virchow's triad: the vascular basis of cerebral injury. Rev Neurol Dis 2008;5 Suppl 1:12.
(54) Lowe GDO. Virchow's triad revisited: abnormal flow. Pathophysiol Haemost Thromb 2004;33(5-6):455-457.
(55) Heppell RM, Berkin KE, McLenachan JM, Davies JA. Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation. Heart 1997;77(5):407-411.
(56) Watson T, Shantsila E, Lip GY. Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited. The Lancet 2009;373(9658):155-166.
(57) Weinreich DJ, Burke JF, Pauletto FJ. Left ventricular mural thrombi complicating acute myocardial infarction. Long-term follow-up with serial echocardiography. Ann Intern Med 1984;100(6):789-794.
(58) Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22(8):983-988.
(59) Camm AJ, Lip GYH, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012;33(21):2719-2747.
(60) Lip GYH. Stroke prevention in Atrial Fibrillation. Eur Heart J 2017;38(1):4-5.
(61) Lip GY, Gibbs CR. Does heart failure confer a hypercoagulable state? Virchow's triad revisited. J Am Coll Cardiol 1999;33(5):1424-1426.
(62) Delewi R, Nijveldt R, Hirsch A, Marcu CB, Robbers L, Hassell, Marriela E C J, et al. Left ventricular thrombus formation after acute myocardial infarction as assessed by cardiovascular magnetic resonance imaging. Eur J Radiol 2012;81(12):3900-3904.
(63) Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59(1):17-20.
(64) Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000;55(8):1172-1179.
(65) Tullio MRD, Sacco RL, Gersony D, Nayak H, Weslow RG, Kargman DE, et al. Aortic atheromas and acute ischemic stroke A transesophageal echocardiographic study in an ethnically mixed population.
Neurology 1996;46(6):1560-1566.
(66) Cannegieter SC, Rosendaal FR, Briët E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994;89(2):635-641.
(67) Brennan JM, Edwards FH, Zhao Y, O'Brien S, Booth ME, Dokholyan RS, et al. Long-term safety and effectiveness of mechanical versus biologic aortic valve prostheses in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. Circulation 2013;127(16):1647-1655.
(68) Merkler AE, Chu SY, Lerario MP, Navi BB, Kamel H. Temporal relationship between infective endocarditis and stroke. Neurology 2015;85(6):512-516.
(69) Elkind MSV. Inflammatory mechanisms of stroke. Stroke 2010;41(10 Suppl):3.
(70) Menke J, Lüthje L, Kastrup A, Larsen J. Thromboembolism in atrial fibrillation. Am J Cardiol 2010;105(4):502-510.
(71) Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare
professionals from the American Heart Association/American Stroke Association. Stroke 2014;45(7):2160-2236.
(72) Lyaker MR, Tulman DB, Dimitrova GT, Pin RH, Papadimos TJ. Arterial embolism. Int J Crit Illn Inj Sci 2013;3(1):77-87.
(73) Lehtimäki TT, Kärkkäinen JM, Saari P, Manninen H, Paajanen H, Vanninen R. Detecting acute
mesenteric ischemia in CT of the acute abdomen is dependent on clinical suspicion: Review of 95 consecutive patients. Eur J Radiol 2015;84(12):2444-2453.
(74) Beinart R, Heist EK, Newell JB, Holmvang G, Ruskin JN, Mansour M. Left atrial appendage dimensions predict the risk of stroke/TIA in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2011;22(1):10-15.
(75) Delewi R, Zijlstra F, Piek JJ. Left ventricular thrombus formation after acute myocardial infarction. Heart 2012;98(23):1743-1749.
(76) Maron BA, Shekar PS, Goldhaber SZ. Paradoxical embolism. Circulation 2010;122(19):1968-1972.
(77) Bang OY, Lee MJ, Ryoo S, Kim SJ, Kim JW. Patent Foramen Ovale and Stroke–Current Status. Journal of Stroke 2015;17(3):229-237.
(78) Kimura K, Minematsu K, Nakajima M. Isolated pulmonary arteriovenous fistula without Rendu-Osler-Weber disease as a cause of cryptogenic stroke. J Neurol Neurosurg Psychiatr 2004;75(2):311-313.
(79) Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med
2001;345(24):1740-1746.
(80) Silver MD, Dorsey JS. Aneurysms of the septum primum in adults. Arch Pathol Lab Med 1978;102(2):62-65.
(81) De Castro S, Cartoni D, Fiorelli M, Rasura M, Anzini A, Zanette EM, et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 2000;31(10):2407-2413.
(82) Arboix A, Oliveres M, Massons J, Pujades R, Garcia-Eroles L. Early differentiation of cardioembolic from atherothrombotic cerebral infarction: a multivariate analysis. Eur J Neurol 1999;6(6):677-683.
(83) Ringelstein EB, Koschorke S, Holling A, Thron A, Lambertz H, Minale C. Computed tomographic patterns of proven embolic brain infarctions. Ann Neurol 1989;26(6):759-765.
(84) Nah H, Lee J, Chung C, Choo S, Kwon SU, Kim JS, et al. New brain infarcts on magnetic resonance imaging after coronary artery bypass graft surgery: lesion patterns, mechanism, and predictors. Ann Neurol 2014;76(3):347-355.
(85) Timsit SG, Sacco RL, Mohr JP, Foulkes MA, Tatemichi TK, Wolf PA, et al. Early clinical differentiation of cerebral infarction from severe atherosclerotic stenosis and cardioembolism. Stroke 1992;23(4):486-491.
(86) Bogiatzi C, Hackam DG, McLeod AI, Spence JD. Secular trends in ischemic stroke subtypes and stroke risk factors. Stroke 2014;45(11):3208-3213.
(87) Dussault C, Toeg H, Nathan M, Wang ZJ, Roux J, Secemsky E. Electrocardiographic monitoring for detecting atrial fibrillation after ischemic stroke or transient ischemic attack: systematic review and meta-analysis. Circ Arrhythm Electrophysiol 2015;8(2):263-269.
(88) Lin HJ, Wolf PA, Kelly-Hayes M, Beiser AS, Kase CS, Benjamin EJ, et al. Stroke severity in atrial fibrillation. The Framingham Study. Stroke 1996;27(10):1760-1764.
(89) Lip GYH. Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why? Eur Heart J 2013;34(14):1041-1049.
(90) Lip GYH, Lane DA. Stroke Prevention in Atrial Fibrillation: A Systematic Review. JAMA 2015;313(19):1950-1962.
(91) Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C. Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project. Stroke 1994;25(2):333-337.
(92) Hardie K, Hankey GJ, Jamrozik K, Broadhurst RJ, Anderson C. Ten-year risk of first recurrent stroke and disability after first-ever stroke in the Perth Community Stroke Study. Stroke 2004;35(3):731-735.
(93) Aguilar MI, Hart R, Pearce LA. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks. Cochrane Database Syst Rev 2007(3):CD006186.
(94) Yaghi S, Moon YP, Mora-McLaughlin C, Willey JZ, Cheung K, Di Tullio MR, et al. Left atrial enlargement and stroke recurrence: the Northern Manhattan Stroke Study. Stroke 2015;46(6):1488-1493.
(95) Broughton ST, O'Neal WT, Salahuddin T, Soliman EZ. The Influence of Left Atrial Enlargement on the Relationship between Atrial Fibrillation and Stroke. J Stroke Cerebrovasc Dis 2016;25(6):1396-1402.
(96) Gardner JD, Skelton WP, Khouzam RN. Is It Time to Incorporate the Left Atrial Size to the Current Stroke Risk Scoring Systems for Atrial Fibrillation?(). Curr Probl Cardiol 2016;41(9-10):251-259.
(97) Pepi M, Evangelista A, Nihoyannopoulos P, Flachskampf FA, Athanassopoulos G, Colonna P, et al.
Recommendations for echocardiography use in the diagnosis and management of cardiac sources of embolism: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr 2010;11(6):461-476.
(98) Yang H, Nassif M, Khairy P, de Groot JR, Roos, Yvo B W E M, de Winter RJ, et al. Cardiac diagnostic work-up of ischaemic stroke. Eur Heart J 2016.
(99) Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31(19):2369-2429.
(100) Nattel S. New ideas about atrial fibrillation 50 years on. Nature 2002;415(6868):219-226.
(101) Lip GYH, Fauchier L, Freedman SB, Gelder IV, Natale A, Gianni C, et al. Atrial fibrillation. Nature Reviews Disease Primers 2016;2:nrdp201616.
(102) Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004;110(9):1042-1046.
(103) Hobbs FDR, Fitzmaurice DA, Mant J, Murray E, Jowett S, Bryan S, et al. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess 2005;9(40):74.
(104) Michelena HI, Ezekowitz MD. Atrial fibrillation: are there gender differences? J Gend Specif Med 2000;3(6):44-49.
(105) Huxley RR, Lopez FL, Folsom AR, Agarwal SK, Loehr LR, Soliman EZ, et al. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2011;123(14):1501-1508.
(106) Nieuwlaat R, Capucci A, Camm AJ, Olsson SB, Andresen D, Davies DW, et al. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation.
Eur Heart J 2005;26(22):2422-2434.
(107) Larsson SC, Drca N, Wolk A. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. J Am Coll Cardiol 2014;64(3):281-289.
(108) Johnson LSB, Juhlin T, Juul-Möller S, Hedblad B, Nilsson PM, Engström G. A prospective study of supraventricular activity and incidence of atrial fibrillation. Heart Rhythm 2015;12(9):1898-1904.
(109) Iwasaki Y, Nishida K, Kato T, Nattel S. Atrial fibrillation pathophysiology: implications for management. Circulation 2011;124(20):2264-2274.
(110) Björck S, Palaszewski B, Friberg L, Bergfeldt L. Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study. Stroke 2013;44(11):3103-3108.
(111) Friberg L, Benson L, Rosenqvist M, Lip GYH. Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study. BMJ 2012;344:e3522.
(112) Mikkelsen AP, Lindhardsen J, Lip GYH, Gislason GH, Torp-Pedersen C, Olesen JB. Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study. J Thromb Haemost 2012;10(9):1745-1751.
(113) Michelena HI, Powell BD, Brady PA, Friedman PA, Ezekowitz MD. Gender in atrial fibrillation: Ten years later. Gend Med 2010;7(3):206-217.
(114) Print MCS. Atrial fibrillation - Symptoms and causes. Available at:
http://www.mayoclinic.org/diseases-conditions/atrial-fibrillation/symptoms-causes/dxc-20164936. Accessed Aug 11, 2017.
(115) Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener H, et al. Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. Europace 2007;9(11):1006-1023.
(116) Brachmann J, Morillo CA, Sanna T, Di Lazzaro V, Diener H, Bernstein RA, et al. Uncovering Atrial Fibrillation Beyond Short-Term Monitoring in Cryptogenic Stroke Patients: Three-Year Results From the Cryptogenic Stroke and Underlying Atrial Fibrillation Trial. Circ Arrhythm Electrophysiol
2016;9(1):e003333.
(117) Frost L, Engholm G, Johnsen S, Møller H, Husted S. Incident stroke after discharge from the hospital with a diagnosis of atrial fibrillation. Am J Med 2000;108(1):36-40.
(118) Jahangir A, Lee V, Friedman PA, Trusty JM, Hodge DO, Kopecky SL, et al. Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study. Circulation
2007;115(24):3050-3056.
(119) Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications.
Circ Arrhythm Electrophysiol 2008;1(1):62-73.
(120) Schotten U, Verheule S, Kirchhof P, Goette A. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev 2011;91(1):265-325.
(121) Boos CJ, Anderson RA, Lip GYH. Is atrial fibrillation an inflammatory disorder? Eur Heart J 2006;27(2):136-149.
(122) Nattel S, Harada M. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. J Am Coll Cardiol 2014;63(22):2335-2345.
(123) Markides V, Schilling RJ. classifica. 4th ed.: Oxford University Press; 2010.
(124) Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339(10):659-666.
(125) Nattel S, Dobrev D. Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation.
Nat Rev Cardiol 2016;13(10):575-590.
(126) Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Mohanty S, Horton R, et al. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation 2010;122(2):109-118.
(127) Anter E, Jessup M, Callans DJ. Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation 2009;119(18):2516-2525.
(128) Kotecha D, Piccini JP. Atrial fibrillation in heart failure: what should we do? European heart journal 2015;36(46):3250.
(129) Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994;271(11):840-844.
(130) Wang TJ, Parise H, Levy D, D’Agostino RB, Wolf PA, Vasan RS, et al. Obesity and the Risk of New-Onset Atrial Fibrillation. JAMA 2004;292(20):2471-2477.
(131) Chen Y, Xu S, Bendahhou S, Wang X, Wang Y, Xu W, et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003;299(5604):251-254.
(132) Roberts JD, Gollob MH. Impact of genetic discoveries on the classification of lone atrial fibrillation. J Am Coll Cardiol 2010;55(8):705-712.
(133) Fox CS, Parise H, D'Agostino RB, Lloyd-Jones DM, Vasan RS, Wang TJ, et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA 2004;291(23):2851-2855.
(134) Furukawa T, Ebana Y. Current overview of the genetic background of atrial fibrillation: Possible therapeutic gene targets for the treatment of atrial fibrillation. Journal of Arrhythmia 2012;28(3):140-144.
(135) Takabayashi K, Hamatani Y, Yamashita Y, Takagi D, Unoki T, Ishii M, et al. Incidence of Stroke or Systemic Embolism in Paroxysmal Versus Sustained Atrial Fibrillation: The Fushimi Atrial Fibrillation Registry. Stroke 2015;46(12):3354-3361.
(136) Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, et al. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. J Am Coll Cardiol 2007;50(22):2156-2161.
(137) Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation. Eur Heart J 2010;31(8):967-975.
(138) Grönberg T, Hartikainen JEK, Nuotio I, Biancari F, Ylitalo A, Airaksinen KEJ. Anticoagulation, CHA2DS2VASc Score, and Thromboembolic Risk of Cardioversion of Acute Atrial Fibrillation (from the FinCV Study). Am J Cardiol 2016;117(8):1294-1298.
(139) Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146(12):857-867.
(140) Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 2014;383(9921):955-962.
(141) Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns, Harry J G M, Lip GYH. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart
(141) Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns, Harry J G M, Lip GYH. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart